Verastem stocktwits
Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced a potential best-in-class KRAS G12D oral inhibitor as the lead program of its discovery and development collaboration with GenFleet Therapeutics (“GenFleet”).Comparatively, 88.4% of Verastem shares are held by institutional investors. 3.8% of Akebia Therapeutics shares are held by insiders. Comparatively, 2.2% of Verastem shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Did you know?
Verastem Oncology. Reconciliation of GAAP to Non-GAAP Financial Information (in thousands, except per share amounts) (unaudited) Three months ended December 31, Year ended December 31, 2022 2021 2022 2021. Net loss reconciliation Net loss (GAAP basis) $ (16,808) $ (16,481) $ (73,812) $ (71,200) ...Verastem, Inc. (NasdaqCM:VSTM) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% ...10.86. +3.43%. Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued.Track VESTIS CORPORATION (VSTS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack ImmunityBio Inc (IBRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors2 days ago · Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven cancers, specifically novel small molecule drugs that inhibit critical signaling pathways in ...The detail page will show you the real-time trend, you can click into the MSN Money website for more detailsVerastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote ...Verastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS pathway-driven tumors as part of its (Raf And Mek Program). RAMP 301 is a Phase 3 confirmatory ...Track OrganiGram Holdings Inc. (OGI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsA few Evernote apps will no longer be updated or available for download in the new year. These include screenshot and annotating tool Skitch and Clearly, which makes web pages more...Aug 15, 2018 · Verastem will retain all rights to duvelisib outside of Japan.” The company has indicated another ex-US partnership by the end of 2018 as seen below. ... The skilled StockTwits user and VSTM ...Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients ...Latest FSRN News. No FSRN news at the moment. Track Fisker Inc (FSRN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...
The Verastem stock price fell by -66.17% on the last day (Friday, 24th May 2024) from $12.18 to $4.12. During the last trading day the stock fluctuated 30.60% from a day low at $4.02 to a day high of $5.25. The price has been going up and down for this period, and there has been a -65.23% loss for the last 2 weeks.A. While ratings are subjective and will change, the latest Verastem ( VSTM) rating was a reiterated with a price target of $0.00 to $17.50. The current price Verastem ( VSTM) is trading at is $11 ...Verastem was founded on the belief that most currently marketed anti-cancer drugs have little efficacy against cancer stem cells (CSCs), a progenitor subgroup of cells that some scientists believe ...Total Valuation. Verastem has a market cap or net worth of $305.43 million. The enterprise value is $237.35 million. Market Cap. 305.43M. Enterprise Value. 237.35M.
About Verastem Oncology. Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that ...Track Braskem S.A. (BAK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMar 14, 2024 · BOSTON, March 14, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three ...…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Learn more. Track Verisign Inc. (VRSN) Stock Price, Quot. Possible cause: STOCKTWITS; INSIDER TRADING; SENTIMENT ANALYSIS; MANAGER PORTFOLIOS; LATE CORPORATE NEW.
Fintel reports that on July 11, 2023, Truist Securities maintained coverage of Verastem (NASDAQ:VSTM) with a Buy recommendation. Analyst Price Forecast Suggests 349.13% UpsideBOSTON, May 25, 2023--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced updated data from Part A of the ...
4.1200. -66.17%. NKTR Nektar Therapeutics. 1.6400. -1.20%. Find the latest Geron Corporation (GERN) stock quote, history, news and other vital information to help you with your stock trading and ...Take care of yourself now, and prepare yourself to act when circumstances change. The past two years have seen a wave of people quitting their jobs—the phenomenon that came to be k...
BOSTON--(BUSINESS WIRE)--Jun. 22, 2020-- Veraste The stock options have an exercise price equal to $7.65 per share, the closing price of Verastem Oncology's common stock as reported by Nasdaq on October 12, 2023.BOSTON, May 31, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 ... We would like to show you a description here buLearn more. Track Stem Inc (STEM) Stock Price, Quo Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Verastem, Inc. Brian Sullivan, 781-292-4214 Director, Corporate Development [email protected] or Infinity Pharmaceuticals, Inc. Jaren Irene Madden, 617-453-1336 Senior Director, Investor Relations and Corporate Communications [email protected]. E-mail Alerts. You may automatically receive Verastem Oncology financial information by e ... Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharm AMERICAN FUNDS MULTI-SECTOR INCOME FUND CLASS 529-F-2- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies StocksWhat this means: Verastem Inc (VSTM) gets a very positive evaluation from InvestorsObserver's ranking system. An Overall Rank of 86 means that our comprehensive methodology rates Verastem Inc above 86% of stocks. Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a … Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmVerastem, Inc. (VSTM) 4.1200 -8.0600 (-66.1At Yahoo Finance, you get free stock quotes, up-to-date news BOSTON--(BUSINESS WIRE)--Jan. 18, 2024-- Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Verastem Oncology’s investigational RAF/MEK … By: Brian Stuglik, CEO, Verastem Oncology. Over the pa Verastem (VSTM) Stock Price, News & Analysis. → WARNING about the death of the U.S. dollar… (From Colonial Metals) Free VSTM Stock Alerts. $4.12. -8.06 ( …Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), ANI Pharmaceuticals (ANIP) and Argenx Se (ARGX) May 13, 2024TipRanks. RBC Capital Sticks to Their Buy Rating for Verastem (VSTM ... 2 days ago · Insiders have sold a total of 16,432 Verastem sha[As Verastem Oncology (NASDAQ:VSTM) sits on the precipiVerastem Oncology (Nasdaq: VSTM) is a dev Find the latest Verastem, Inc. (VSTM) stock quote, history, news and other vital information to help you with your stock trading and investing.